Treatment with LB-102 was generally safe and well-tolerated. The most common adverse events were insomnia, headache, anxiety, and agitation, consistent with existing antipsychotics. Increases in prolactin were observed with few clinical adverse events associated with those increases. Modest weight gain was also observed but was not associated with a clinically meaningful signal in metabolic parameters.
1 Like
1 Like
1 Like